RxDoctor Payments Data

Prema Jacob, MD

Family Medicine · Loveland, CONPI 1487633533

Payments from drug & device makers

$7,676in general payments, 2019–2025

Across 311 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • AbbVie$1K
  • Abbott$627
  • Eko Health, Inc.$600
  • Lilly USA, LLC$420
  • GSK$385
  • plus $3K from 45 others

What the payments were for

  • Speaking & faculty fees$6008%
  • Travel & lodging$78610%
  • Food & beverage$6,17280%
  • Education$1182%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,676 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$197,354
Medicare patients
320
Services billed
6,938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide79$91,576
OzempicSemaglutide40$54,111
JardianceEmpagliflozin32$39,438
EliquisApixaban20$20,673
JanuviaSitagliptin Phosphate21$18,796
CreonLipase/Protease/Amylase26$16,304
NovologInsulin Aspart11$1,907
Rosuvastatin Calcium272$1,837
Levothyroxine Sodium141$1,277
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,125
Losartan Potassium160$1,066
Armour ThyroidThyroid,pork11$969
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$964
Memantine Hcl15$886
Carvedilol178$855

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$420$91,57679 claims
Novo NordiskOzempic, Novolog$135$56,01951 claims
Boehringer IngelheimJardiance$22$39,43832 claims
PfizerEliquis$133$20,67320 claims
MerckJanuvia$210$18,79621 claims
AbbVieCreon, Armour Thyroid$1,282$17,27337 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Loveland

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →